Skip to main content
. 2021 Apr 1;53(5):102048. doi: 10.1016/j.aprim.2021.102048

Table 2.

Clinical features of depression associated with frailty.

Non-frail (n = 216) Frail (n = 122) p OR (95% CI)
Major depression 70 (32.9%) 55 (45.1%) 0.026 1.68 (1.062–2.649)
Dysthymia 47 (22.3%) 28 (23.1%) 0.856 1.05 (0.617–1.789)



Suicide risk
 None 154 (73.7%) 75 (65.2%) 1
 Low 48 (23.0%) 29 (25.2%) 0.063 1.24 (0.725–2.123)
 Moderate 5 (2.4%) 5 (4.3%) 2.05 (0.577–7.311)
 High 2 (1.0%) 6 (5.2%) 6.16 (1.214–31.249)



Family history of depression 69 (34.2%) 34 (31.2%) 0.596 0.87 (0.531–1.439)
Psychiatric admission 15 (7.7%) 12 (11.5%) 0.269 1.56 (0.704–3.482)



Cognitive impairment (MMSE)
 None 53 (57.6%) 37 (51.4%) 1
 Possible 11 (12.0%) 14 (19.4%) 0.408 1.823 (0.745–4.459)
 Mild or moderate 28 (30.4%) 21 (29.2%) 1.074 (0.531–2.173)



Anxiety 44 (30.1%) 15 (34.1%) 0.619 1.20 (0.59–2.46)



Depression symptoms(HDRS)
 None (0–7) 90 (45.5%) 27 (22.9%) 1
 Mild (8–13) 73 (36.9%) 39 (33.1%) 1.78 (0.997–3.180)
 Moderate (14–18) 26 (13.1%) 32 (27.1%) <0.001 4.10 (2.093–8.040)
 Severe (19–22) 7 (3.5%) 12 (10.2%) 5.71 (2.047–15.951)
 Very severe (>23) 2 (1.0%) 8 (6.8%) 13.33 (2.670–66.575)



Years since diagnosisa 10 (5.0–20.0) 15 (7.8–23.0) 0.021 1.01 (0.99–1.03)
Use of any psychiatric drug 197 (95.2%) 118 (98.3%) 0.142 2.995 (0.64–)
Use of antidepressants 169 (82.4%) 111 (92.5%) 0.011 2.627 (1.218–5.667)
Use of anxiolytics 92 (51.1%) 64 (59.8%) 0.152 1.424 (0.877–2.311
Use of antiepileptics 14 (9.0%) 3 (3.7%) 0.130 0.385 (0.107–1.381)
Use of AchEIs 2 (1.3%) 1 (1.2%) 0.963 0.944 (0.84–10.574)
a

Median and interquartile range.

AchEI, acetylcholinesterase inhibitor; HDRS, Hamilton Depression Rating Scale; MMSE, Mini Mental State Exam.